Phase IV studies

Post-marketing studies

Post-marketing studies are vital for continuing to monitor the safety, efficacy and optimal use of marketed drugs and biologics. SCRO has the know-how and resources to help you plan and conduct post-marketing studies to gather real world clinical data in order to assess your product’s safety and efficacy profile throughout its lifecycle.

Phase IV studies, or post-marketing studies, are performed after the product has been approved for market and are important large-scale studies that can identify previously unknown safety issues.

In addition, post-marketing studies can be used to study a specific subpopulation of patients; compare your product to similar drugs or biologics on the market; or monitor long-term-effectiveness, health economy or product quality.

Post-marketing studies

Gain better understanding

Let SCRO support you in planning and carrying out your post-marketing study from start to finish, or by providing standalone services that meet your needs, budget and timelines.

Learn more

Providing expertise
since 2007

Whether you need qualified and comprehensive consultancy services or targeted first-class assistance, we are here to help. Across Scandinavia and beyond.

Get in touch

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.